Lirk Philipp, Bodrogi Florian, Raifer Hartmann, Greiner Karin, Ulmer Hanno, Rieder Josef
Department of Anesthesiology and Critical Care Medicine, Leopold Franzens University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
Nephrol Dial Transplant. 2003 May;18(5):937-41. doi: 10.1093/ndt/gfg049.
Uraemic odour is a characteristic feature of patients with end-stage renal disease (ESRD). However, few investigations have been carried out into the composition of exhaled air in ESRD patients undergoing haemodialysis (HD). Increases of exhaled isoprene levels by a factor of up to 2.7 following HD have been reported.
We attempted to confirm these findings in 50 patients undergoing HD using haemophan (n=23) or polysulphone (n=27) dialysis membranes. Parallel evaluation of ambient air, calorie intake, medication and haemodynamic variables was performed. Samples were analysed using proton transfer reaction-mass spectrometry (PTR-MS).
Significant changes in breath isoprene concentration were observed when comparing patients before [39.14+/-14.96 parts per billion (ppbv)] and after (63.54+/-27.59 ppbv) dialysis (P<0.001). The quotient of values before and after dialysis was 1.84 (SD 1.41). No significant differences in isoprene kinetics were found between the use of haemophan and polysulphone membranes. No significant correlations were observed between isoprene quotients and variations in blood pressure during HD, calorie intake, ingestion of lipid-lowering drugs or serum lipid levels.
Isoprene concentration was higher in the exhaled air of patients after HD as compared with values before HD. Large interindividual variability existed in isoprene kinetics. Oxidative stress appears to be an unlikely cause for this rise. An alternative hypothesis is an influence of respiratory variables on isoprene exhalation based upon Henry's law constant. We therefore propose to perform online monitoring of isoprene exhalation by PTR-MS during the HD session to investigate the possible influence of respiratory variables.
尿毒症气味是终末期肾病(ESRD)患者的一个特征。然而,针对接受血液透析(HD)的ESRD患者呼出气体成分的研究却很少。有报道称,HD后呼出的异戊二烯水平最多可升高2.7倍。
我们试图在50例使用血仿膜(n = 23)或聚砜膜(n = 27)进行HD的患者中证实这些发现。同时对环境空气、热量摄入、药物治疗和血流动力学变量进行评估。使用质子转移反应质谱法(PTR-MS)对样本进行分析。
比较透析前[39.14±14.96十亿分之一(ppbv)]和透析后(63.54±27.59 ppbv)的患者时,观察到呼出异戊二烯浓度有显著变化(P < 0.001)。透析前后数值的商为1.84(标准差1.41)。使用血仿膜和聚砜膜之间在异戊二烯动力学方面未发现显著差异。在HD期间,异戊二烯商与血压变化、热量摄入、降脂药物摄入或血脂水平之间未观察到显著相关性。
与HD前相比,HD后患者呼出气体中的异戊二烯浓度更高。异戊二烯动力学存在较大的个体间差异。氧化应激似乎不太可能是这种升高的原因。另一种假说是基于亨利定律常数,呼吸变量对异戊二烯呼出有影响。因此,我们建议在HD过程中通过PTR-MS对异戊二烯呼出进行在线监测以研究呼吸变量的可能影响。